DS3790a

· Daiichi Sankyo

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DS3790a, covering 2026-03-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies [Phase 1, Phase 2]